Polymeric nanocarriers for the treatment of systemic iron overload

Desferrioxamine (DFO), deferiprone (L1) and desferasirox (ICL-670) are clinically approved iron chelators used to treat secondary iron overload. Although iron chelators have been utilized since the 1960s and there has been much improvement in available therapy, there is still the need for new drug c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, Jasmine L, Kizhakkedathu, Jayachandran N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451967/
https://www.ncbi.nlm.nih.gov/pubmed/26056604
http://dx.doi.org/10.1186/s40591-015-0039-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451967/
https://www.ncbi.nlm.nih.gov/pubmed/26056604
http://dx.doi.org/10.1186/s40591-015-0039-1

Ejemplares similares